Voyager Therapeutics grants stock options and restricted stock units to new employee Dr. Eric Hall.

From GlobeNewswire: 2024-07-23 16:01:00

Voyager Therapeutics, Inc. has granted Dr. Eric Hall a non-qualified stock option and restricted stock units as an inducement for joining the company. The stock option allows the purchase of 36,000 shares at $8.77 per share, while the restricted stock unit represents 18,000 shares. Both awards vest over several years and are subject to Dr. Hall’s continued employment. Voyager Therapeutics is focused on developing neurogenetic medicines to treat neurological diseases like Alzheimer’s, ALS, and Parkinson’s. The company utilizes its TRACER™ AAV capsid discovery platform to advance its pipeline of treatments. Contact information for Voyager Therapeutics is available for investors and media inquiries.



Read more at GlobeNewswire: Voyager Therapeutics Announces Inducement Grants Under